Jci_page_head_homepage_01 Jci_page_head_homepage_02
Rohit N. Kulkarni, Jonathon N. Winnay, Molly Daniels, Jens C. Brüning, Sarah N. Flier, Douglas Hanahan, C. Ronald Kahn
Published in Volume 104, Issue 12
J Clin Invest. 1999; 104(12):R69–R75 doi:10.1172/JCI8339
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 2

Impaired glucose tolerance and reduced acute phase insulin release in IRS-1–/– mice. Intraperitoneal (IP) injection of (a and b) glucose (3 g/kg body weight) or (c) L-arginine (0.3 g/kg body weight) shows an impaired glucose tolerance and a reduced insulin response in IRS-1–/– mice compared with age-matched WT controls. Whole blood was collected from tail vein samples at the indicated times for insulin measurements. Values are means ± SEM (n = 4–6). *P < 0.05 versus WT.